Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients
Gisselbrecht, C.; Oksenjendler, E.; Tirelli, U.; Gabarre, J.; Gastaldi, R.; Farcet, J.P.; Thyss, A.; Coiffier, B.; Raphael, M.; Lepage, E.
Leukemia 6(Suppl 3): 10s-11s
1992
ISSN/ISBN: 0887-6924 PMID: 1376380 Document Number: 389568
Document emailed within 1 workday
Related Documents
Yang, C.-J.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Hung, C.-C.; Chang, S.-C. 2010: Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan Journal of Microbiology Immunology and Infection 43(4): 278-284Charton-Bain, M.C.; Le Tourneau, A.; Weiss, L.; Bruneval, P.; Diebold, J. 1997: Rare non-Hodgkin's lymphoma in the course of infection with human immunodeficiency virus. two cases with bone marrow invasion Annales de Pathologie 17(1): 38-40
Mwanda, O.W.; Whalen, C.; Scot, C.R.; Lederman, M.; Orem, J.; Banura, C. 2004: Anatomical site predilections of non-Hodgkin's lymphoma in human immunodeficiency virus infection: a report on 54 cases East African Medical Journal 2004(8 Suppl): S90-S96
Kragel, P.J.; Miller, L.K.; Casafrancisco, D. 1992: Aspiration cytology of lymphocyte-depleted Hodgkin's lymphoma in a man infected with the human immunodeficiency virus. A case report Acta Cytologica 36(3): 395-398
Khagi, S.; Danilova, O.; Rauwerdink, C. 2012: Hemophagocytic syndrome in a patient with human immunodeficiency virus, Epstein-Barr viremia, and newly diagnosed Hodgkin lymphoma Clinical Advances in Hematology and Oncology: H&o 10(4): 260-262
Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
de Lima e Costa, M.F.; Proietti, F.A.; Paulino, U.H.; Silva, E.A.; Lasmar, E.P.; Antunes, C.M.; Guimarães, M.D.; Greco, D.B. 1987: Human immunodeficiency virus infection in selected hemodialysis patients in Belo Horizonte, Brazil Revista Da Sociedade Brasileira de Medicina Tropical 20(4): 225-226
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Spina, M.; Vaccher, E.; Nasti, G.; Tirelli, U. 2000: Human immunodeficiency virus-associated Hodgkin's disease Seminars in Oncology 27(4): 480-488
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Guarner, J.; Brynes, R.K.; Chan, W.C.; Birdsong, G.; Hertzler, G. 1987: Primary non-Hodgkin's lymphoma of the heart in two patients with the acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 111(3): 254-256